|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Agenda Items
|
||||||||||||||||||||||
|
1 - Opening and Election of the Chairing Committee,
|
||||||||||||||||||||||
|
2 - Review, discussion and approval of the Annual Report of the Company for the fiscal year 2024 as prepared by the Board of Directors,
|
||||||||||||||||||||||
|
3 - Presentation of the summary of the Independent Audit Report for the year 2024,
|
||||||||||||||||||||||
|
4 - Review, discussion and approval of the 2024 Financial Statements,
|
||||||||||||||||||||||
|
5 - Release of the members of the Board of Directors from liability for the affairs of the Company for the year 2024,
|
||||||||||||||||||||||
|
6 - Approval of the amendment to be made to the Company's "Dividend Distribution Policy" for the year 2025 and the following years in accordance with the Capital Markets Board regulations,
|
||||||||||||||||||||||
|
7 - Within the framework of the Company's dividend policy; approval, amendment or disapproval of the Board of Directors' proposal on profit distribution of year 2024 and the date of dividend distribution,
|
||||||||||||||||||||||
|
8 - Approval, approval with amendments or rejection of the Board of Directors' proposal on the amendment of Article 6 titled as "Capital" of the Company's Articles of Association, for the purpose of increasing the registered capital ceiling and extending its validity period,
|
||||||||||||||||||||||
|
9 - Determination of the number of Board Members, their term of office, election of members in accordance with the number determined and election of Independent Board Members,
|
||||||||||||||||||||||
|
10 - In accordance with the Corporate Governance Principles, presentation to shareholders and approval by the General Assembly of the "Remuneration Policy" for the members of the Board of Directors and the Senior Executives and the payments made on that basis,
|
||||||||||||||||||||||
|
11 - Resolution of annual gross salaries of the Members of the Board of Directors,
|
||||||||||||||||||||||
|
12 - Approval of the Independent Audit Firm as selected by the Board of Directors, in accordance with the provisions of the Turkish Commercial Code, the Capital Markets Board regulations and Public Oversight, Accounting and Auditing Standards Authority,
|
||||||||||||||||||||||
|
13 - Presentation to shareholders of the donations made by the Company in 2024 and resolution of an upper limit for donations to be made for 2025 as per the "Donation and Sponsorship Policy",
|
||||||||||||||||||||||
|
14 - In accordance with the Capital Markets Board regulations, presentation to shareholders of the securities, pledges and mortgages granted in favour of the third parties in the year 2024 and of any benefits or income thereof,
|
||||||||||||||||||||||
|
15 - Authorization of the shareholders with management control, the members of the Board of Directors, the senior executives and their spouses and relatives related by blood or affinity up to the second degree as per the provisions of Articles 395 and 396 of the Turkish Commercial Code and presentation to shareholders, of the transactions carried out thereof in the year 2024 pursuant to the Corporate Governance Communique of the Capital Markets Board,
|
||||||||||||||||||||||
|
16 - Informing the Shareholders about the Strategic Transition Plan announced by Tüpraş regarding the low-carbon economy transition plan and the work carried out in 2024 within the scope of the plan,
|
||||||||||||||||||||||
|
17 - Wishes and Opinions.
|
||||||||||||||||||||||
|
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
In accordance with CMB's Principles on Corporate Governance, information and documents regarding the agenda items that will be discussed in the Ordinary General Assembly Meeting on March 27, 2025 are made available in the attached file and The Company's web site address of www.tupras.com .tr for the information of our shareholders and investors. This statement has been translated intro English for informational purposes, in case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish versiyon shall prevail. |